Sepsis: Definitions and diagnosis

International Journal of Clinical Practice, Supplement

Volumn , Issue 95, 1998, Pages 44-48

  Karzai, Waheedullah ^a   Reinhart, Konrad ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CALCITONIN;

BACTERIOLOGY; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE MARKER; FEVER; HUMAN; HYPOTENSION; HYPOXEMIA; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTOSIS; MEDICAL RESEARCH; MENTAL DISEASE; METABOLIC ACIDOSIS; MULTIPLE ORGAN FAILURE; OLIGURIA; PRIORITY JOURNAL; SEPSIS; TACHYCARDIA; TACHYPNEA; ARTICLE; BLOOD; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BIOLOGICAL MARKERS; CALCITONIN; CYTOKINES; HUMANS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0031595648     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Bone RC, Fisher CJ, Clemmer TP et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317: 653-658
2. Bone RC, Fisher CJ, Clemmer TP et al. The methylprednisolone severe sepsis study group. Sepsis syndrome: a valid clinical entity. Crit Care Med 1989; 17: 389-393.
3. Bone RC. Let's agree on terminology: definitions of sepsis. Crit Care Med 1991; 19: 973-976.
4. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.
5. Vincent JL, Bihari D. Sepsis, severe sepsis, or sepsis syndrome: need for clarification. Intensive Care Med 1992; 18: 255-257.
6. Zeni F, Freeman BD, Nathanson C. Antiinflammatory therapies to treat sepsis and septic shock - a reassessment. Crit Care Med 1997; 25(7): 1095-1100.
7. Gramm H-J, Reinhart K, Goecke J, Bülow J von. Early clinical, laboratory, and hemodynamic indicators of sepsis and septic shock. In: Reinhart K, Eyrich K, eds. Sepsis - An Interdisciplinary Challenge. Berlin: Springer-Verlag, 1989: 45-57.
8. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994; 330: 1198-1205.
9. Moore FA, Haenel JB, Moore EE, Whitehill TA. Incommensurate oxygen consumption in response to maximal oxygen availability predicts post injury multiple organ failure. J Trauma 1992; 33: 58-67.
10. Saffle JR, Sullivan JJ, Tuohig GM, Larson CM. Multiple organ failure in patients with thermal injury. Crit Care Med 1993; 21: 1673-1683.
11. Natanson C, Hoffman WD, Suffredini AF et al. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994; 120: 771-783.
12. Reinhart K, Wiegend-Löhnert C, Grimminger F et al. Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Crit Care Med 1996; 24: 733-742.
13. Assicot M, Gendrel D, Carsin H et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 34: 515-518.
14. Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K. Procalcitonin - a new indicator of the systemic response to severe infections. Infection 1997; 25: 329-334.